ATE296639T1 - Melanoma therapie - Google Patents

Melanoma therapie

Info

Publication number
ATE296639T1
ATE296639T1 AT00107101T AT00107101T ATE296639T1 AT E296639 T1 ATE296639 T1 AT E296639T1 AT 00107101 T AT00107101 T AT 00107101T AT 00107101 T AT00107101 T AT 00107101T AT E296639 T1 ATE296639 T1 AT E296639T1
Authority
AT
Austria
Prior art keywords
melanoma therapy
melanoma
therapy
Prior art date
Application number
AT00107101T
Other languages
English (en)
Inventor
Mary Ellen Rybak
Esther Helen Rose
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE296639T1 publication Critical patent/ATE296639T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
AT00107101T 1999-04-08 2000-04-06 Melanoma therapie ATE296639T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28836699A 1999-04-08 1999-04-08

Publications (1)

Publication Number Publication Date
ATE296639T1 true ATE296639T1 (de) 2005-06-15

Family

ID=23106795

Family Applications (3)

Application Number Title Priority Date Filing Date
AT08020311T ATE496631T1 (de) 1999-04-08 2000-04-06 Melanomtherapie
AT05002951T ATE419001T1 (de) 1999-04-08 2000-04-06 Melanoma therapie
AT00107101T ATE296639T1 (de) 1999-04-08 2000-04-06 Melanoma therapie

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT08020311T ATE496631T1 (de) 1999-04-08 2000-04-06 Melanomtherapie
AT05002951T ATE419001T1 (de) 1999-04-08 2000-04-06 Melanoma therapie

Country Status (22)

Country Link
EP (3) EP1043026B1 (de)
JP (1) JP2000319195A (de)
CN (1) CN1390132A (de)
AR (1) AR023398A1 (de)
AT (3) ATE496631T1 (de)
AU (1) AU771569B2 (de)
BR (1) BR0009646A (de)
CA (1) CA2303992A1 (de)
CO (1) CO5170404A1 (de)
CY (1) CY1108922T1 (de)
DE (3) DE60041290D1 (de)
DK (2) DK1043026T3 (de)
ES (2) ES2319776T3 (de)
HK (2) HK1032349A1 (de)
HU (1) HU230057B1 (de)
MY (1) MY126763A (de)
NO (1) NO328111B1 (de)
PE (1) PE20010027A1 (de)
PT (2) PT1535622E (de)
TW (1) TWI292320B (de)
WO (1) WO2000061175A2 (de)
ZA (1) ZA200108173B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX360254B (es) 2011-03-10 2018-10-26 Pfizer Combinacion de terapias inmunomoduladoras local y sistemica para tratamiento mejorado del cancer.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4492537A (en) 1982-12-10 1985-01-08 Awerkamp John B Fluid-operated oil or water well pump
US4917888A (en) 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
JP2514950B2 (ja) 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質,その製造法および中間体
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
WO1995013090A1 (en) 1993-11-10 1995-05-18 Enzon, Inc. Improved interferon polymer conjugates
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
TW426523B (en) 1995-04-06 2001-03-21 Hoffmann La Roche Interferon solution
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates

Also Published As

Publication number Publication date
AR023398A1 (es) 2002-09-04
BR0009646A (pt) 2002-02-05
CA2303992A1 (en) 2000-10-08
EP1043026A2 (de) 2000-10-11
EP2025344A1 (de) 2009-02-18
EP2025344B1 (de) 2011-01-26
EP1535622A1 (de) 2005-06-01
CN1390132A (zh) 2003-01-08
AU771569B2 (en) 2004-03-25
AU4204600A (en) 2000-11-14
DK1043026T3 (da) 2005-07-04
DK1535622T3 (da) 2009-04-20
CO5170404A1 (es) 2002-06-27
DE60020444T2 (de) 2006-05-04
PE20010027A1 (es) 2001-02-05
DE60045591D1 (de) 2011-03-10
JP2000319195A (ja) 2000-11-21
ES2239954T3 (es) 2005-10-16
NO20014852D0 (no) 2001-10-05
HU230057B1 (hu) 2015-06-29
ATE496631T1 (de) 2011-02-15
DE60041290D1 (de) 2009-02-12
PT1535622E (pt) 2009-03-19
ES2319776T3 (es) 2009-05-12
HK1075416A1 (en) 2005-12-16
HUP0200775A3 (en) 2002-09-30
EP1535622B1 (de) 2008-12-31
EP1043026A3 (de) 2000-12-20
MY126763A (en) 2006-10-31
ATE419001T1 (de) 2009-01-15
DE60020444D1 (de) 2005-07-07
WO2000061175A2 (en) 2000-10-19
ZA200108173B (en) 2003-01-06
TWI292320B (en) 2008-01-11
EP1043026B1 (de) 2005-06-01
CY1108922T1 (el) 2014-07-02
HUP0200775A2 (en) 2002-08-28
PT1043026E (pt) 2005-09-30
WO2000061175A3 (en) 2001-02-01
NO20014852L (no) 2001-12-06
NO328111B1 (no) 2009-12-07
HK1032349A1 (en) 2001-07-20

Similar Documents

Publication Publication Date Title
DK1637127T3 (da) Terapeutisk mikroskum
NO20021400D0 (no) Terapeutiske konazolinderivater
DE69924365D1 (de) Massagegerät
ID27841A (id) Turunan-turunan biaril terapeutik
PT1060695E (pt) Cadeira empilhavel
PT1235558E (pt) Agentes terapeuticos
NO20014490L (no) Medisinske blandinger
DE60017816D1 (de) Herzschrittmacher
ATE284637T1 (de) Matratze
DE60016600D1 (de) Herzschrittmacher
DE59911113D1 (de) Herzschrittmacher
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
ITMI991895A0 (it) Depigmentanti cutanei
DE60013608D1 (de) Herzschrittmacher
DE50010867D1 (de) Abdeckvorrichtung
NO20016301D0 (no) Terapeutiske midler
DE60016452D1 (de) Herzschrittmacher
DE29818627U1 (de) Therapiestuhl
DE60041290D1 (de) Melanoma Therapie
DE29905089U1 (de) Behandlungsliege
DE29822274U1 (de) Saunaliege
FI19992468A (fi) Tuoli
DE29800356U1 (de) Sonnenbank
DE50005638D1 (de) Abdeckvorrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1043026

Country of ref document: EP